Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

138 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Efficiency of prostate-specific antigen and digital rectal examination in screening, using 4.0 ng/ml and age-specific reference range as a cutoff for abnormal values.
Crawford ED, Leewansangtong S, Goktas S, Holthaus K, Baier M. Crawford ED, et al. Among authors: goktas s. Prostate. 1999 Mar 1;38(4):296-302. doi: 10.1002/(sici)1097-0045(19990301)38:4<296::aid-pros5>3.0.co;2-p. Prostate. 1999. PMID: 10075009 Clinical Trial.
Prostate cancer and adiponectin.
Goktas S, Yilmaz MI, Caglar K, Sonmez A, Kilic S, Bedir S. Goktas S, et al. Urology. 2005 Jun;65(6):1168-72. doi: 10.1016/j.urology.2004.12.053. Urology. 2005. PMID: 15922427
A prospective controlled study to determine the duration of antibiotherapy in the patients with elevated serum PSA levels.
Topac H, Goktas S, Basal S, Zor M, Yildirim I, Dayanc M. Topac H, et al. Among authors: goktas s. Minerva Urol Nefrol. 2016 Jun;68(3):270-4. Epub 2014 Jul 11. Minerva Urol Nefrol. 2016. PMID: 25014678
Selective Low-Dose Spinal Anesthesia for Transrectal Prostate Biopsy: A Prospective and Randomized Study.
Kucur M, Goktas S, Kaynar M, Apiliogullari S, Kilic O, Akand M, Gul M, Celik JB. Kucur M, et al. Among authors: goktas s. J Endourol. 2015 Dec;29(12):1412-7. doi: 10.1089/end.2015.0450. Epub 2015 Sep 8. J Endourol. 2015. PMID: 26176605 Clinical Trial.
Benign prostatic hyperplasia and prostate cancer differentiation via platelet to lymphocyte ratio.
Kaynar M, Yildirim ME, Gul M, Kilic O, Ceylan K, Goktas S. Kaynar M, et al. Among authors: goktas s. Cancer Biomark. 2015;15(3):317-23. doi: 10.3233/CBM-150458. Cancer Biomark. 2015. PMID: 25586096
Comparability of serum prostate-specific antigen measurement between the hybritech Tandem-R and Abbott AxSYM assays.
Leewansangtong S, Goktas S, Lepoff R, Holthaus K, Crawford ED. Leewansangtong S, et al. Among authors: goktas s. Urology. 1998 Sep;52(3):467-9. doi: 10.1016/s0090-4295(98)00210-6. Urology. 1998. PMID: 9730462
A cross-sectional study of vasectomy, time since vasectomy and prostate cancer.
DeAntoni EP, Göktaş S, Stenner J, O'Donnell C, Crawford ED. DeAntoni EP, et al. Among authors: goktas s. Prostate Cancer Prostatic Dis. 1997 Dec;1(2):73-78. doi: 10.1038/sj.pcan.4500209. Prostate Cancer Prostatic Dis. 1997. PMID: 12496919
Combined androgen blockade for advanced prostatic carcinoma.
Goktas S, Ziada A, Crawford ED. Goktas S, et al. Prostate Cancer Prostatic Dis. 1999 Jul;2(4):172-179. doi: 10.1038/sj.pcan.4500323. Prostate Cancer Prostatic Dis. 1999. PMID: 12496774
The choice of hormonal therapy for carcinoma of the prostate depends not only on the desired progression-free and overall survival but also on the patient's quality of life, treatment costs and treatment toxicities. ...
The choice of hormonal therapy for carcinoma of the prostate depends not only on the desired progression-free and overall survival but also …
Optimal hormonal therapy for advanced prostatic carcinoma.
Goktas S, Crawford ED. Goktas S, et al. Semin Oncol. 1999 Apr;26(2):162-73. Semin Oncol. 1999. PMID: 10597727 Review.
The choice of hormonal therapy for carcinoma of the prostate depends not only on the desired progression-free and overall survival, but also on the patient's quality of life, treatment costs, and treatment toxicities. ...
The choice of hormonal therapy for carcinoma of the prostate depends not only on the desired progression-free and overall survival, but also …
CYP1A2, CYP2D6, GSTM1, GSTP1, and GSTT1 gene polymorphisms in patients with bladder cancer in a Turkish population.
Altayli E, Gunes S, Yilmaz AF, Goktas S, Bek Y. Altayli E, et al. Among authors: goktas s. Int Urol Nephrol. 2009;41(2):259-66. doi: 10.1007/s11255-008-9444-6. Epub 2008 Aug 9. Int Urol Nephrol. 2009. PMID: 18690546
The objective of this study was to investigate the relationship between bladder tumor and variants of cytochrome p450 1A2 (CYP1A2) 734 C --> A, cytochrome p450 2D6 (CYP2D6) 1934 G --> A, glutathione S-transferase M1, (GSTM1 null), glutathione S-transferase T1 …
The objective of this study was to investigate the relationship between bladder tumor and variants of cytochrome p450 1A2 (CYP1A2) 734 C --& …
138 results
Jump to page
Feedback